Rankings
▼
Calendar
RXRX Q1 2020 Earnings — Recursion Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
RXRX
Recursion Pharmaceuticals, Inc.
$2B
Q1 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$18M
Net Income
-$18M
EPS (Diluted)
$-0.11
Cash Flow
Operating Cash Flow
-$18M
Free Cash Flow
-$19M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$0
Total Liabilities
$0
Stockholders' Equity
$77M
Cash & Equivalents
-$70M
← FY 2020
All Quarters
Q2 2020 →
